Related Experiment Video
Updated: Mar 19, 2026

Robot-assisted Total Mesorectal Excision and Lateral Pelvic Lymph Node Dissection for Locally Advanced Middle-low Rectal Cancer
Published on: February 12, 2022
Automatic segmentation software in locally advanced rectal cancer: READY (REsearch program in Auto Delineation
Maria A Gambacorta1, Luca Boldrini1, Chiara Valentini1
1Department of Radiation Oncology, Sacred Heart Catholic University of Rome, Rome, Italy.
Autocontouring software for rectal cancer shows promise, partially meeting clinical validation criteria. While time savings were significant, overlap metrics require further improvement for full adoption.
Area of Science:
- Radiation Oncology
- Medical Imaging Analysis
Background:
- Autocontouring software (AS) aims to improve efficiency in radiation therapy planning.
- Clinical validation is crucial to ensure the accuracy and reliability of AS for specific cancer sites like rectal cancer.
Purpose of the Study:
- To validate autocontouring software (AS) for rectal cancer delineation in a clinical setting.
- To assess the performance of AS against expert manual delineation using established quality assurance (QA) metrics.
Main Methods:
- Two radiation oncologists established reference contours for 44 rectal cancer patients.
- AS was populated with 14 cases and tested on 30 cases, comparing manual (Group A) and automatic (Group B) delineations.
- Metrics analyzed included Median Dice Similarity Coefficient (MDSC), Mean Slicewise Hausdorff Distances (MSHD), and Total-Time saving (TT).
Main Results:
- The AS achieved an MDSC of 0.75, MSHD of 2.00 mm, and 55.5% TT saving compared to manual delineation.
- Expert inter-observer agreement (MDSC) was 0.84.
- The system partially met the predefined acceptance criteria (MDSC ≥ 0.75, MSHD ≤ 1mm, TT saving ≥ 50%), with at least two criteria needing to be met, including TT saving.
Conclusions:
- Current autocontouring systems for rectal cancer offer significant time savings but do not fully meet the stringent overlap criteria for clinical validation.
- Further software development is needed to improve delineation accuracy and meet all validation benchmarks.
More Related Videos
13:01Industrialized, Artificial Intelligence-guided Laser Microdissection for Microscaled Proteomic Analysis of the Tumor Microenvironment
Published on: June 3, 2022
06:05Author Spotlight: Multiplex Immunofluorescence Combined with Spatial Image Analysis for the Clinical and Biological Assessment of the Tumor Microenvironment
Published on: June 2, 2023